vs

Side-by-side financial comparison of Crane NXT, Co. (CXT) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $387.7M, roughly 1.7× Crane NXT, Co.). Natera, Inc. runs the higher net margin — 7.1% vs 1.7%, a 5.5% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 17.4%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $-24.1M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 2.3%).

Crane Co. is an American industrial products company based in Stamford, Connecticut. Founded by Richard Teller Crane in 1855, it became one of the leading manufacturers of bathroom fixtures in the United States, until 1990, when that division was sold off. In 1960 it began the process of becoming a holding company with a diverse portfolio. Its business segments are Aerospace & Electronics, Engineered Materials, Fluid Handling, and Controls. Industries served by these segments include chemical...

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

CXT vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.7× larger
NTRA
$665.5M
$387.7M
CXT
Growing faster (revenue YoY)
NTRA
NTRA
+22.4% gap
NTRA
39.8%
17.4%
CXT
Higher net margin
NTRA
NTRA
5.5% more per $
NTRA
7.1%
1.7%
CXT
More free cash flow
NTRA
NTRA
$61.9M more FCF
NTRA
$37.8M
$-24.1M
CXT
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
2.3%
CXT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CXT
CXT
NTRA
NTRA
Revenue
$387.7M
$665.5M
Net Profit
$6.4M
$47.3M
Gross Margin
40.2%
Operating Margin
-3.4%
Net Margin
1.7%
7.1%
Revenue YoY
17.4%
39.8%
Net Profit YoY
-70.5%
187.9%
EPS (diluted)
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXT
CXT
NTRA
NTRA
Q1 26
$387.7M
Q4 25
$476.9M
$665.5M
Q3 25
$445.1M
$592.2M
Q2 25
$404.4M
$546.6M
Q1 25
$330.3M
$501.8M
Q4 24
$399.1M
$476.1M
Q3 24
$403.5M
$439.8M
Q2 24
$370.6M
$413.4M
Net Profit
CXT
CXT
NTRA
NTRA
Q1 26
$6.4M
Q4 25
$47.5M
$47.3M
Q3 25
$50.5M
$-87.5M
Q2 25
$24.9M
$-100.9M
Q1 25
$21.7M
$-66.9M
Q4 24
$-53.8M
Q3 24
$47.1M
$-31.6M
Q2 24
$41.6M
$-37.5M
Gross Margin
CXT
CXT
NTRA
NTRA
Q1 26
40.2%
Q4 25
42.4%
Q3 25
43.3%
Q2 25
41.7%
Q1 25
42.4%
Q4 24
45.2%
Q3 24
42.5%
Q2 24
43.4%
Operating Margin
CXT
CXT
NTRA
NTRA
Q1 26
Q4 25
16.7%
-3.4%
Q3 25
18.4%
-16.5%
Q2 25
11.8%
-20.2%
Q1 25
11.3%
-15.8%
Q4 24
17.7%
-13.6%
Q3 24
18.6%
-8.9%
Q2 24
18.2%
-10.6%
Net Margin
CXT
CXT
NTRA
NTRA
Q1 26
1.7%
Q4 25
10.0%
7.1%
Q3 25
11.3%
-14.8%
Q2 25
6.2%
-18.5%
Q1 25
6.6%
-13.3%
Q4 24
-11.3%
Q3 24
11.7%
-7.2%
Q2 24
11.2%
-9.1%
EPS (diluted)
CXT
CXT
NTRA
NTRA
Q1 26
Q4 25
$0.82
$0.36
Q3 25
$0.87
$-0.64
Q2 25
$0.43
$-0.74
Q1 25
$0.38
$-0.50
Q4 24
$1.00
$-0.41
Q3 24
$0.81
$-0.26
Q2 24
$0.72
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXT
CXT
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$228.3M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$1.2B
$1.7B
Total Assets
$3.6B
$2.4B
Debt / EquityLower = less leverage
1.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXT
CXT
NTRA
NTRA
Q1 26
$228.3M
Q4 25
$233.8M
Q3 25
$182.4M
$1.0M
Q2 25
$152.5M
$16.0M
Q1 25
$173.8M
$17.8M
Q4 24
$165.8M
$22.7M
Q3 24
$165.1M
$29.5M
Q2 24
$175.5M
$90.3M
Total Debt
CXT
CXT
NTRA
NTRA
Q1 26
$1.5B
Q4 25
$1.0B
Q3 25
$834.3M
Q2 25
$861.8M
Q1 25
$541.1M
Q4 24
$540.6M
Q3 24
$638.2M
Q2 24
$638.9M
Stockholders' Equity
CXT
CXT
NTRA
NTRA
Q1 26
$1.2B
Q4 25
$1.3B
$1.7B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.2B
Q1 25
$1.1B
$1.2B
Q4 24
$1.1B
$1.2B
Q3 24
$1.1B
$878.5M
Q2 24
$989.8M
$836.5M
Total Assets
CXT
CXT
NTRA
NTRA
Q1 26
$3.6B
Q4 25
$3.1B
$2.4B
Q3 25
$2.9B
$1.8B
Q2 25
$2.9B
$1.8B
Q1 25
$2.4B
$1.7B
Q4 24
$2.4B
$1.7B
Q3 24
$2.4B
$1.6B
Q2 24
$2.4B
$1.5B
Debt / Equity
CXT
CXT
NTRA
NTRA
Q1 26
1.22×
Q4 25
0.80×
Q3 25
0.69×
Q2 25
0.73×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.60×
Q2 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXT
CXT
NTRA
NTRA
Operating Cash FlowLast quarter
$73.9M
Free Cash FlowOCF − Capex
$-24.1M
$37.8M
FCF MarginFCF / Revenue
-6.2%
5.7%
Capex IntensityCapex / Revenue
2.6%
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXT
CXT
NTRA
NTRA
Q1 26
Q4 25
$105.8M
$73.9M
Q3 25
$92.0M
$59.4M
Q2 25
$62.8M
$37.6M
Q1 25
$-19.1M
$44.5M
Q4 24
$81.1M
$52.9M
Q3 24
$66.7M
$51.8M
Q2 24
$56.8M
$4.0M
Free Cash Flow
CXT
CXT
NTRA
NTRA
Q1 26
$-24.1M
Q4 25
$37.8M
Q3 25
$78.7M
$37.0M
Q2 25
$55.8M
$11.7M
Q1 25
$-32.2M
$22.6M
Q4 24
$34.8M
Q3 24
$53.5M
$35.5M
Q2 24
$47.9M
$-7.7M
FCF Margin
CXT
CXT
NTRA
NTRA
Q1 26
-6.2%
Q4 25
5.7%
Q3 25
17.7%
6.2%
Q2 25
13.8%
2.1%
Q1 25
-9.7%
4.5%
Q4 24
7.3%
Q3 24
13.3%
8.1%
Q2 24
12.9%
-1.9%
Capex Intensity
CXT
CXT
NTRA
NTRA
Q1 26
2.6%
Q4 25
5.4%
Q3 25
3.0%
3.8%
Q2 25
1.7%
4.7%
Q1 25
4.0%
4.3%
Q4 24
3.8%
Q3 24
3.3%
3.7%
Q2 24
2.4%
2.8%
Cash Conversion
CXT
CXT
NTRA
NTRA
Q1 26
Q4 25
2.23×
1.56×
Q3 25
1.82×
Q2 25
2.52×
Q1 25
-0.88×
Q4 24
Q3 24
1.42×
Q2 24
1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXT
CXT

Detection and Traceability Technologies$194.9M50%
Security and Authentication Technologies$192.8M50%

NTRA
NTRA

Segment breakdown not available.

Related Comparisons